Charles Dulberger Email and Phone Number

I lead highly collaborative preclinical research teams that lay the groundwork for better vaccines and immunotherapies against infectious diseases and cancer. I built a structural biology core that uses x-ray crystallography, cryo-EM and computational structure prediction to power protein engineering for biologics R&D and vaccine antigen design. This work is built on skill sets I gathered during my PhD training with Erin Adams, where I used structural biology to understand how MHC molecules regulate immunity via interactions with T and NK cell receptors. During my postdoctoral work with Eric Rubin, I studied antibiotic and phage resistance mechanisms in bacterial pathogens, such as salmonella and tuberculosis. At BioNTech, I’ve continued cultivating knowledge of infectious diseases, such as TB, malaria, poxviruses, herpesviruses and coronaviruses. I’ve used this expertise to power IND-enabling studies bringing next-generation vaccines with huge potential for global impact to the clinic.